The antiphospholipid syndrome (APS) is defined by the presence of thrombosis and/or
pregnancy morbidity in combination with the persistent presence of circulating …

Antiphospholipid syndrome (APS) is characterised by vascular thrombosis and/or obstetric
morbidity in the presence of persistently positive antiphospholipid antibodies (aPL) …

ContextAntiphospholipid antibodies are autoantibodies directed against proteins that bind to
phospholipid. Antiphospholipid antibody syndrome (APS) refers to the association between …

For patients with antiphospholipid syndrome (APS), the consensus is to treat those who
develop thrombosis with long-term oral anticoagulation therapy and to prevent obstetric …

BACKGROUND AND OBJECTIVE: The clinical importance of antiphospholipid antibodies
(APA) derives from their association with a syndrome of venous and arterial thrombosis …

See also Galli M. The antiphospholipid triangle. This issue, pp 234–6. Summary
Background: The characteristics and the clinical course of antiphospholipid syndrome (APS) …

The antiphospholipid syndrome (APS) is defined by venous or arterial thrombosis and/or
pregnancy morbidity in patients with persistent presence of antiphospholipid antibodies …

Antiphospholipid syndrome is an autoimmune systemic disorder characterized by arterial,
venous, or small vessel thrombosis and/or recurrent early pregnancy loss, fetal loss, or …

Persistently positive antiphospholipid antibodies (aPLs) with thrombosis and/or pregnancy
morbidity are the hallmark of the antiphospholipid syndrome. However, aPL-positive patients …

Antiphospholipid antibody syndrome (APS) is an autoimmune acquired thrombophilia
characterized by recurrent thrombosis and pregnancy morbidity in the presence of …